• ALMOTRIPTAN CHEMBL1505 FDA Approved

    Alternate Names:

    Almotriptan
    LAS-31416
    1-(((3-(2-(DIMETHYLAMINO)ETHYL)INDOL-5-YL)METHYL)SULFONYL)PYRROLIDINE
    AC1L3WYP
    AXERT
    KBIOGR_001647
    NCGC00095135-01
    KBIOSS_002414
    UNII-1O4XL5SN61
    CHEBI:520985
    DAP000218
    NCGC00095135-02
    I06-0492
    700325
    KBIO2_007544
    KBIO2_004976
    BRD-K67601717-001-02-0
    HMS1922L13
    ALMOTRIPTAN [USAN:INN:BAN]
    PNU-180638
    DB00918
    181183-52-8
    SPBIO_000395
    ALMOGRAN
    SPECTRUM1505204
    MOLPORT-003-666-604
    KBIO3_001951
    PYRROLIDINE, 1-(((3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-5-YL)METHYL)SULFONYL)-
    SPECTRUM3_001006
    LS-173461
    BSPBIO_002731
    CID123606
    D02824
    SPECTRUM2_000498
    154323-57-6
    SPECTRUM_001884
    ALMOTRIPTAN (USAN)
    NCGC00095135-03
    123606
    SPECTRUM4_001134
    SPECTRUM5_001554
    C17H27N3O2S
    L000846
    BIDD:GT0048
    KBIO2_002408
    ALMOTRINTAN
    N,N-DIMETHYL-2-(5-((PYRROLIDIN-1-YLSULFONYL)METHYL)-1H-INDOL-3-YL)ETHAN-1-AMINE
    N,N-DIMETHYL-5-[(1-PYRROLIDINYLSULFONYL)METHYL]-1H-INDOLE-3-ETHANAMINE
    N,N-DIMETHYL-2-[5-(1-PYRROLIDINYLSULFONYLMETHYL)-1H-INDOL-3-YL]ETHANAMINE
    DIMETHYL(2-{5-[(PYRROLIDINE-1-SULFONYL)METHYL]-1H-INDOL-3-YL}ETHYL)AMINE
    1H-INDOLE-3-ETHANAMINE, N,N-DIMETHYL-5-[(1-PYRROLIDINYLSULFONYL)METHYL]-
    1-[[3-(2-DIMETHYLAMINOETHYL)-5-INDOLYL]METHANESULPHONYL]PYRROLIDINE
    A809522
    TC-133341
    DB-064033
    HE314291
    DR001617
    AK-78697
    AJ-08395
    NCGC00095135-05
    NCGC00095135-04
    NSC-760092
    EBD2201889
    AM84500
    TOX21_111444_1
    AKOS015895080
    NSC760092
    FC0030
    DAP001345
    CCG-39569
    ANW-44596
    AN-689
    TOX21_111444
    TOX21 111444
    PHARMAKON1600-01505204
    ZINC18087
    HY-B0383A
    CTK8B4281
    GTPL7110
    1O4XL5SN61
    SCHEMBL1957
    ALMOTRIPTAN;
    AXERTREG
    CAS-154323-57-6
    DSSTOX_GSID_44289
    DSSTOX_RID_80142
    DSSTOX_CID_24289
    WKEMJKQOLOHJLZ-UHFFFAOYSA-N
    12014867

    Drug Info:

    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antimigraine agent
    Year of Approval 2001
    Drug Class anti-migraine agents
    (1 More Sources)

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Trial Name almotriptan,Axert, Almogran, Amignul
    Novel drug target Established target

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name almotriptan,Axert, Almogran, Amignul
    Novel drug target Established target

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    ALMOTRIPTAN Primary Drug Name

    Drug Info:
    Drug Class anti-migraine agents
    Year of Approval 2001

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antimigraine agent
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    KBIO2_002408 Drug Synonym
    BIDD:GT0048 Drug Synonym
    L000846 Drug Synonym

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    ALMOTRIPTAN [USAN:INN:BAN] Drug Synonym
    LAS-31416 Drug Synonym
    AXERT Drug Synonym

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    ALMOTRIPTAN pubchem_primary_name
    123606 PubChem CID
    154323-57-6 Drug Synonym

    Drug Info:

    Publications: